Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2003
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424911A 焦虑方法 Anxiety method
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424396A Preparation of implanting neurons for treating nerve injury diseases
06/18/2003CN1424318A Structure of phenethyl alcohol glycoside compound and its use
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424106A Medicines for treating depression and preparation thereof
06/18/2003CN1424073A Medicine for treating insomnia-sleeping particle and preparation thereof
06/18/2003CN1424055A Tea or wine preparation for preventing senile dementia
06/18/2003CN1424045A Cell growth regulating factor B and preparation thereof
06/18/2003CN1424037A Water soluble dressing materials of ziracitone and its salts and their preparation
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111421C Natural drug-dropping medicine
06/18/2003CN1111416C Insomnic plaster
06/18/2003CN1111408C Pyridyl-and pyrimidyl-piperazines in treatment of substance abuse disorders
06/18/2003CN1111402C Tramadol multiple unit formulations
06/17/2003US6579987 Diaryl-enynes
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579903 Klainetins and their derivatives, method for their preparation and use thereof
06/17/2003US6579899 Composition for treatment of stress
06/17/2003US6579898 Compositions having improved bioavailability
06/17/2003US6579895 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579886 Ionotropic glutamate receptors; 6-((4-carboxylic acid-1H-imidazol-1-yl)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3 -carboxylic acid
06/17/2003US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579878 Pharmaceutical compositions and methods for use
06/17/2003US6579875 Triazolo-pyridazine derivatives as ligands for GABA receptors
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/17/2003US6579867 Azepin-2-one derivatives useful for treating Alzheimer's disease
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579858 Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579853 For inhibiting apoptosis or apoptosis-like cell death
06/17/2003US6579851 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579689 Modulation of γ-secretase activity
06/17/2003US6579536 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003CA2291133C Method for the preparation of citalopram
06/17/2003CA2290973C Encapsulated solution dosage forms of sertraline
06/17/2003CA2118114C Potentiation of antimicrobial effects
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048773A2 Methods for monitoring amyotrophic lateral sclerosis
06/12/2003WO2003048384A2 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
06/12/2003WO2003048354A1 Protein-decomposing/eliminating enzyme and utilization thereof
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048165A1 ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048164A2 Adenosine a2a receptor antagonists
06/12/2003WO2003048163A1 [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048147A2 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
06/12/2003WO2003048146A1 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048137A1 Metabotropic glutamate receptor-5 modulators
06/12/2003WO2003048132A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/12/2003WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003048118A1 5-ht7 receptor antagonists
06/12/2003WO2003048117A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003048113A1 Tramadol analogs and uses thereof
06/12/2003WO2003047635A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
06/12/2003WO2003047625A1 Neural transmission promoters
06/12/2003WO2003047622A1 Remedies for multiple sclerosis
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047589A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/12/2003WO2003047588A1 Kit for reducing aching caused by pde-v inhibitors
06/12/2003WO2003047581A1 Acetylene derivatives having mglur 5 antagonistic activity
06/12/2003WO2003047580A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047576A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
06/12/2003WO2003047574A1 Pharmaceutical composition comprising a derivative of 5-phenoxyalkyl-2,4-thiazolidinedione type and a 4-oxobutanoic acid
06/12/2003WO2003047570A1 Benzazole derivatives for the treatment of scleroderma
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047562A1 Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment
06/12/2003WO2003047561A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
06/12/2003WO2003047560A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
06/12/2003WO2003047558A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors
06/12/2003WO2003047556A1 Transdermal therapeutic system provided with improved long-term carrying comfort
1 ... 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 ... 1833